跳至主要内容
临床试验/NCT02017990
NCT02017990已完成不适用

The Levels of Marine n-3 Polyunsaturated Fatty Acids in Plasma Phospholipids as a Prognostic Marker of Mortality and Graft Loss Endpoints in Renal Transplant Recipients.

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 2,002 人开始时间: 1999年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,002
试验地点
1
主要终点
All-cause mortality

研究概览

简要总结

This study will evaluate the association between n-3 polyunsaturated fatty acids and patient and graft survival. The association between other fatty acids and mortality and graft loss endpoints will also be evaluated.

详细描述

This observational study focuses on the effects of marine n-3 polyunsaturated fatty acids (PUFAs) intake, measured as fatty acid levels in plasma phospholipids, and mortality and graft loss endpoints in renal transplant recipients. Data on morbidity, mortality and graft loss in The Norwegian Renal Registry is matched against data on fatty acid composition in a large renal transplantation cohort of approximately 2000 patients with a median follow up time of about 5 years. It is a follow up study, although retrospectively evaluated. It will evaluate the role of marine n-3 PUFAs as a prognostic marker in renal transplantation by investigating the association between the levels (weight percentage of total fatty acids) of marine n-3 PUFAs in plasma phospholipids and events, including mortality and graft loss.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Received a renal transplant. Signed informed consent.

排除标准

  • Under the age of 16 years.

结局指标

主要结局

All-cause mortality

时间窗: Up to 12 years.

First patient recruited October 1999 and all remaining patients were censored at August 2012.

次要结局

  • Loss of function in the renal transplant.(Up to 12 years.)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验